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Spectacular Failure-A View from the Epicenter
Mary Crewe*
The question these billions ask is-what are you doing you in whom we have
placed our trust, what are you doing to end the deliberate and savage violence
against us that, everyday, sentences many of us to a degrading and unnecessary
death!
-President Thabo Mbeki, U.N. Millennium Summit, 20001
INTRODUCTION
In 2000, at the XIII International AIDS Conference in Durban, Jeffrey
Sachs spoke of the "shocking disregard" shown by the international
community in its failure to respond to the AIDS epidemic.2 "How could the
world," he asked, "have stood by for the first 20 years of this pandemic,
letting it reach 35 to 40 million people before any real funding started?" 3
Two years later, at the XIV International AIDS Conference in Barcelona,
speakers again decried the world's inaction; Dr. Peter Piot, Executive
Director of the Joint United Nations Programme on HIV/AIDS
(UNAIDS), lamented, "Why are only 30,000 Africans getting antiretroviral
treatment, when a hundred times that number need it?"
4
It was at the Barcelona Conference that an inspiring call was issued to
* Director, Centre for the Study of AIDS, University of Pretoria, South Africa.
1. South African President Thabo Mbeki, Statement at the U.N. Millennium Summit
(Sept. 7, 2000), http://www.anc.org.za/ancdocs/history/mbeki/2000/tmO907.htm (last
visited Jan. 7, 2004). See generally Tim TrengoveJones, CTR. FORTHE STUDYOF AIDS, Who
Cares? AIDS Review 2001, http://www.csa.za.org/filemanager/list/3/ (last visitedJan. 7,
2004) (discussing Mbeki's speech at the U.N. Millennium Summit).
2. Jon Cohen, Companies, Donors Pledge to Close Gap in AIDS Treatment, 289 SCIENCE 368,
368 (2000) (quoting Sach's comments at the XIII International AIDS Conference).
3. Id.
4. Peter Piot, Keeping the Promise, Address at the Opening Ceremonies of the XIV
International AIDS Conference (July 7, 2002),
http://www.hivandhepatitis.com/2002conf/14thaids/4.html (last visistedJan. 7, 2004).
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make antiretroviral (ARV) treatment available to three million people in
the developing world by the end of 2005. 5 Providing treatment to three
million-when twenty million are infected-does not seem like an
ambitious plea. Yet, even this somewhat modest goal is unlikely to be
reached, given the ongoing failure to mobilize international resources for
the provision of HIV/AIDS drugs in the developing world. Just a few
months ago, on the very day the World Health Organization launched its
5.5 billion dollar so-called "three by five" plan to meet the treatment
challenge outlined in Barcelona in 2002," speculation about the
organization's inability to meet the plan's financial requirements began toS7
appear in the media-leaving many to wonder whether the next
International AIDS Conference will be yet another reprise of the previous
two.
At the very least, the implications of this failure to mobilize resources
will need to be recognized at the upcoming 2004 International AIDS
Conference in Bangkok. The responsibility for the largely avoidable deaths
that have resulted from this failure must be laid firmly where it belongs.
Unfortunately, it belongs everywhere: Responsibility lies with the
international community, particularly the wealthy G8 countries which have
been unwilling to adequately support the Global Fund on AIDS,
Tuberculosis and Malaria. It lies with the United Nations, which has failed
to exercise decisive leadership. It also lies with governments in Africa,
which have not met their obligations to their own citizens. Finally, and
most generally, responsibility for these catastrophic losses lies within an
approach towards globalization and development that lacks a moral
foundation, and in doing so, often pits economics against ethics. These
failures have combined to produce one of the greatest betrayals and
tragedies of all time.
5. Thomas H. Maugh, Bleak AIDS Conference Reports Deliver a Global Reality Check, L.A.
TIMES, July 15, 2002, at A3.
6. See Gautam Naik, U.N. Agency Sets $5.5 Billion Plan To Fight AIDS: World Health
Organization Aims to Distribute Drugs To 3 Million by End of 2005, WALL ST.J., Dec. 1, 2003, at
B4, available at http://www.aegis.com/news/wsj/20O3/WJO31201.html (last visited Dec. 17,
2003).
7. See, e.g., id.; WHO Launches Campaign To Give Life-Extending Drugs to 3 Million with
AIDS by 2005, Africa Recovery, at
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AFRICAN AIDS-THE EPICENTER OF THE CRISIS
The statistics describing the HV/AIDS epidemic are well known and
need little elaboration, but a brief reminder is timely. No region has been
harder hit by AIDS than sub-Saharan Africa, which is home to over seventy
percent of those infected by HIV-nearly thirty million adults and children
in the region are living with HIV.8
Why have African countries been so badly affected? What are the
factors influencing individual and community vulnerability? The answers
to these questions are many, and have triggered sometimes heated debate
among economists, social development experts, epidemiologists and
behavioral scientists. Among the many responsible factors are the legacies
of colonialism and neo-colonialism, poverty and economic
underdevelopment, the effects of structural adjustment, the failure of rural
agriculture, continuing gender inequalities, lack of good quality education,
differences in sexual behavior and political indifference and denial." These
conditions, combined with the world's inability-or perhaps
unwillingness-for many years to talk about the Africa of AIDS, have made
HV/AIDS the most serious threat the continent has yet faced. '° More than
twenty million Africans have died-many at the height of their productive
and reproductive years-stretching the medical, educational and welfare
capacity of states beyond their limits, undermining development efforts
and casting a shadow over the future of the continent."
Ensuring access to essential ARV medications and health education
would have an enormous impact on the rate and pace of the epidemic in
Africa, on the ability of people, families and communities to deal with HIV
and AIDS, and on the ability of Africa to meet development challenges and
ultimately to take its rightful place in the world. There is currently an
unprecedented international interest in the African epidemic. Much is
written about the need for treatments and the urgent need to mobilize
resources to secure the provision of ARV drugs, but thus far little has come
of this.
8. See UNAIDS, AIDS EPIDEMIC UPDATE (Dec. 2003), available at
http://www.unaids.org/wad/2003/Epiupdate2OO3-en/Epi0303-en.htm#TopOfPage.
9. Mary Crewe & Peter Aggleton, Racism and HIVIA1DS and Africa, 10 S. AFR.J. INT'L
AFF. 140 (2003).
10. Id. at 141.
11. See CAROLYN BAYLIES ET AL., AIDS, SEXUALITIY AND GENDER IN AFRICA 1 (2000);
HIV/AIDS in Africa, The World Bank, at http://www.worldbank.org/afr/aids/ (last visited
Jan. 6, 2004).
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From the ground, it seems clear that we have not yet answered the
simple question "Does the international community care about African
AIDS?"' 2 Inspiring declarations and promising protocols are relatively easy
to draft. Indeed, in recent years, increased commitments at the
international, regional and domestic levels toward the realization of
human rights related to HIV/AIDS, including improved access to
treatment, have been enthusiastically adopted. 3 Yet, in the end, - it is
concrete actions that count. And to date, there has been regrettably little
action to demonstrate the concern of the United Nations, the
international community, and even of many of Africa's sovereign
governments. From the epicenter of the pandemic it is with disbelief that
one comes to realize the stark reality of international trade and intellectual
property agreements, and how these are allowed to trump creative and
imaginative plans to quickly develop treatment routes, which hold the
potential to save lives and to vest real meaning in the many existing
political statements. 14
Since 1996, people with HIV and AIDS who live in well-resourced
countries have benefited from taking a combination of HIV ARV drugs.
These drugs have resulted in an enormous decrease in'the number of
people dying from AIDS-related illnesses.15 Many people who were seriously
12. Jones, supra note 1, first asked this question in reviewing the response of the
international community.
13. Key among these are the Declaration of Commitment on HIV/AIDS, the
Millennium Development Goals, General Comment Fourteen of the Committee on
Economic, Social and Cultural Rights, and resolutions by the Commission on Human
Rights on the right to the highest attainable standard of health and access to medication.
There is growing recognition that fundamental principles of human rights dictate that
essential medical goods, services and information should not only be universally available,
acceptable and of good quality, but also within physical reach and affordable for all.
14. The impact of trade negotiations on the accessibility of drugs in the developing
world is of tremendous concern to many public health advocates. See, e.g., Brook Baker, U.S.
Trade Negotiations with the South African Customs Union Undermine Access to Medicines and Violate
U.S. Law (July 7, 2003), at
http://www.cptech.org/ip/health/trade/sacu/hgap7072003.html (last visitedJan. 7,
2004);
Press Release, Health GAP, "Free Trade" Costs Lives: Access to Medicines, the AIDS Crisis,
and the Free Trade Area of the Americas (June 2003),
http://www.healthgap.org/press-releases/03/0603_HGAPFTAA.pdf (last visitedJan. 7,
2004); see also
Ellen 't Hoen, TRIPS, Pharmaceutical Patents, and Access to Essential Medicines: A Long Way from
Seattle toDoha, 3 CHI.J. INT'L L. 27 (2002).
15. Senegal and Uganda are countries where effective education programs have
IV:I1 (2004)
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ill have been able to return to work. Yet, most Africans living with
HIV/AIDS do not have the opportunity to make such decisions about their
health and to exercise choice about which medications to use. Despite a
significant decline in the prices of principal ARVs in Africa, these life-
sustaining drugs remain out-of-reach for more than ninety-five percent of
those whose lives they would save.16
One is tempted to ask if an underlying racism towards Africa lies
beneath the complacency that allows this treatment gap to persisit and
even to grow. As in colonial times, do the lives of Africans not matter when
profits and trade are at stake? Is the failure to mobilize international
resources for the provision of drugs to the developing world-thereby
creating large-scale denial of treatment-colonialism of a special kind?
There is a great deal of rhetoric about providing treatments in Africa,
which slides between myth and reality. 17 Arguments are raised about the
economic viability of AIDS treatments in Africa, about the greater
effectiveness of prevention, about the danger of starting treatments that
cannot be sustained potentially leading to the development of resistant
viruses, and about Africa's weak and underdeveloped health
infrastructure." These concerns are seldom raised in Europe or in North
America, and it is particularly incomprehensible that the lack of
infrastructure should still be an argument when we now have so much data
available on the viability of treatment in resource poor settings."9 Much of
the resistance to large-scale funding of programs to combat HIV/AIDS in
Africa is grounded in a discourse about the continent's inadequacy, its
corruption, its poor governance, and its need for technical assistance and
capacity building. Even "development agencies" have rightly drawn
criticism for exaggerating and constructing many of the so-called problems
worked, coupled in some cases with treatment programs. Botswana remains a very
interesting example of treatment access that to date seems to be having little impact on the
epidemic and stigma.
16. See, e.g., Robert Walgate, As AIDS Drug Prices Plummet for Third World, Questions Still
Abound, THE SCIENTIST, Apr. 3, 2001, at
http://www.biomedcentral.com/news/20010403/04/.
17. See Hans Bingswanger, Willingness to Pay for AIDS Treatments: Myths and Realities, 362
LANCET 1152 (2003).
18. See id.
19. See, e.g.,Jennifer Singler & Paul Farmer, Treating HiVin Resource-Poor Settings, 288
JAMA 1652 (2002); see alsoJustice Edwin Cameron, Opening Address at AIDS in Context
Conference, University of Witwatersrand, South Africa (Apr. 4, 2001) (transcript available
at the South African History Archive).
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that keep African countries from "developing., 20 While there is some truth
to the criticisms-there are some examples of corruption, some poor
governance-the fact that these examples have taken over the discourse
can be seen as the arrival of the new colonialists, whose language silences
the voices of the continent and in doing so treats Africa as if it were one
homogenous whole, a move which fails to acknowledge many areas of
success and advancement.
Given the host of current statements of international commitment and
intent regarding provisions for HIV/AIDS,' one cannot help but return to
the simple question: What has gone wrong? Why have promises been made
but not kept? 2 Why does it seem that Africa is simply not important
enough for the commitments to be translated into sustained action-for
serious work to begin with governments to develop ARV programs and
care initiatives? Perhaps the answer lies in a new accomplice to the familiar
specter of colonialism: the phenomenon of globalization. In this modern
world of globalization, people are only as important as the financial and
trade returns they give to the world order, and Africa, with her stumbling
economies and falling share of the world trade exports, does not offer
enough in return. Indeed, most Africans are worse off now than they were
twenty-five years ago and sub-Saharan Africa has the world's lowest rate of
economic growth.2 Compounding this problem are the annual debt
repayments of the continent, which if channeled into HIV/AIDS drugs
would provide more than the projected amounts needed to address the
epidemic effectively. 24 These economic conditions foment a dangerous
relationship between the new trends of globalization and old attitudes of
colonialism, whereby the suffering of those afflicted with diseases such as
20. SeeJAMEs FERGUSON, THE ANTI-POLITIcS MACHINE: "DEVELOPMENT," DEPOLITICIZATION,
AND BUREAUCRATIc POWER IN LESOTHO (1990).
21. See supra note 13.
22. At the Barcelona Conference in 2002, Peter Piot poignantly and aptly remarked,
"Together, we have moved beyond the point where world leaders have ignored our pleas.
The promises have been made. Now, they need to be kept." Piot, supra note 4. For a
discussion of the delays in Bush' promised emergency AIDS funds, see, for example, Linda
Bilmes, Op-Ed, A Poor Start for Bush's Aids Programme, FIN. TIMES, July 7, 2003, available at
http://www.informationclearinghouse.info/article4043.htm (last visitedJan. 7, 2004).
23. For an expanded discussion, see AFRICA IN CRISIS: NEW CHALLENGES AND POSSIBILITIES
(Tunde Zack-Williams et al. eds., 2002).
24. The debt repayment figures for Africa exceed the amount needed by the Global
Fund on AIDS, TB and Malaria. See Peris Jones, When "Development" Devastated: Donor
Discourses, Access to H1V/AIDS Treatment in Africa and Reconstituting the Terrain of
Development, Seminar at the University of Pretoria Department of Sociology (May 2003).
IV:I1 (2004)
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AIDS becomes an economic condition for the "developers" to overcome.
True, Africa's economic development challenges are formidable, and the
ferocity of the AIDS epidemic both exacerbates these issues and gives an
important urgency to them, but to meet these challenges the nature of the
engagement of the Western nations with African countries must change.
Globalization needs to have an ethical dimension added to it-a moral
foundation from which it will serve to address, as a priority, the issues of
poverty and marginalization and not to intensify them.
CONCLUSION
The failure of the international community to mobilize the resources
needed to ensure that Africans have access to treatment is an affront to all
humanity, notjust to the millions of people living with HIV who at the very
least would like to be able to exercise choice with regard to treatment
options. From the financial and political capitals of the world it is easy to
romanticize poverty and local attempts to deal with it. And it is easy, while
not confronted daily with the reality of this epidemic to debate about
international trade, security issues, profits and the costs of intellectual
property and research.
No matter how much anguish is expressed, no matter how many times
the reality of the suffering is exposed and the deaths mourned, what
counts is that those with the capacity and the resources to act to save
millions of people, have not. It is hard not to read this response as
underpinned by racism, a callous lack of real concern, and a spectacular
failure of commitment to the rights, dignity and life of all Africans.
25. See Ethical Globalization Initiative, at http://www.egiinitiative.com (last visited Dec.
17, 2003).
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